A method for preparing uniformly dispersed cultures of Nocardia asteroides for use in tests for susceptibility to antimicrobial agents is described. The minimal inhibiting concentration (MIC) of 45 agents for cultures thus prepared was determined with the use of a replica-inoculating apparatus. Minocycline at a concentration of 3.1 ,ug or less/ml inhibited 90% of the strains tested, and all were inhibited by 6.3 Mg/mi. An erythromycin concentration of 0.8 ,g or less/ml inhibited 40% of the strains, but the MIC for most of the others was > 100 ,ug/ ml. The other agents were generally less active. Chemically related analogues varied in activity to different degrees. Also, the MIC of each antibiotic against different strains generally varied over a wide range. Sulfonamides and trimethoprim were not active against most strains in the method used. The size of the inoculum markedly affected the MIC of sulfonamides and had variable effects on other agents. Marked synergy of erythromycin with ampicillin was demonstrated for nearly all strains tested.
Nocardia asteroides is one of the opportunistic pathogens which are being encountered with increasing frequency in infections of patients under prolonged treatment with corticosteroids and immunosuppressive agents (7, 8, 10, 12) . Sulfonamides have generally been considered the drugs of choice for the therapy of nocardiosis. However, we recently encountered two patients with pulmonary nocardiosis who required other therapy. In one of these patients the sulfonamides failed to influence the infection because of resistance of the organism, and in the other they could not be used because they produced serious drug reactions. Therapy selected on the basis of the in vitro susceptibility of the isolates of N. asteroides cultured from these patients resulted in clinical improvement and eradication of the organisms from the sputum and lungs. This experience prompted us to test the susceptibility of a number of strains to most of the available and useful antibiotics, including several new analogues which are under investigation but not yet approved for therapeutic use.
MATERIALS AND METHODS Organisms. Ruth E. Gordon (Institute of Microbiology, Rutgers University, New Brunswick, N.J.) kindly provided transplants of 70 strains of N. asteroides on agar slants, and 5 strains were recently isolated, four of them by A. Kathleen Daly from patients with systemic nocardiosis at Boston City Hospital and one at another hospital. All were characterized as N. asteroides by the following criteria. They were gram-positive with branching filaments and were weakly acid fast when carbol fuchsin stain was decolorized with 1% sulfuric acid. No growth occurred in 0.4% gelatin. They did not hydrolyze casein and, with few exceptions, did not ferment lactose or mannitol (5).
Preparation of inoculum. Early in this study it became apparent that strains of N. asteroides differ markedly in their growth in liquid media. Some grew at 37 C to a uniformly turbid suspension of up to 109 colony-forming units (CFU) per ml within 48 hr, with the medium having a pH of 8.0 at that time, as described by Gordon and Hagan (6) . In contrast, other strains tended to clump during growth or required up to 10 days to attain similar numbers of CFU. In this study, only cultures which achieved moderate density within 10 days were selected to test for susceptibility.
A loopful of the heavy growth from an agar slant of each organism was shaken into 2 ml of an enrichment broth prepared according to a formula suggested by R. E. Gordon (personal communication 
Results
The results of all of the tests for susceptibility are displayed in Fig. 1-5 . Related antibiotics have been grouped together in the same figure for the most part, but in some instances it was necessary, for clarity and convenience, to combine some unrelated agents.
Penicillins and cephalosporins. None of the 10 penicillins or the 8 cephalosporins was highly active against the strains of N. asteroides that were tested ( Fig. 1 and 2 ). With few exceptions, the MIC was 12.5 ,ug/ml or greater. The most active of the penicillinase-susceptible penicillins were amoxicillin, ampicillin, and epicillin, in decreasing order, as shown in the lower panel of Fig. 1 ; at a concentration of 50 Mg/ml, they inhibited 74, 58, and 45% of the strains, respectively. Only about one-half of the strains were inhibited by 200 Mg of benzylpenicillin/ ml, and only a much smaller proportion were inhibited by that concentration of carbenicillin or BRL-2288. The penicillinase-resistant penicillins were of similarly low activity (Fig. 2) ; a concentration of oxacillin, cloxacillin, nafcillin, and methicillin of 200 Ag/ml inhibited 65, 37, 18, and 4% of the strains, respectively, and very few were inhibited by smaller concentrations.
Cephaloridine at a concentration of 50 ,ug/ml inhibited 59% of the strains (Fig. 2) , and was the most active of the cephalosporins against most of the strains. Cefoxitin inhibited 40%o at 50 Mg/ml. Three of the new analoguescephapirin, cephanone, and cefazolin-were nearly as active; all strains were inhibited by 100 Mg of cephapirin/ml and by 200 Mg of the other two/ml, as shown in upper panel of Fig. 1 .
Aminoglycosides. The six aminoglycoside antibiotics differed widely in their relative activity against the strains tested (Fig. 3) . In addition, the individual strains likewise varied widely in their susceptibility to each of these six antibiotics. A new member of this class, BB-K8 (Bristol Laboratories), was the most active; it inhibited all strains at a concentration of 25 Mg/ml and 50% of them at 6.3 Mg/ml. The other new aminoglycoside, tobramycin, inhibited one-half of the strains at 12.5 ,ug/ml, but one-fourth of them were resistant to 50 gg/ml. Of the four aminoglycosides that are in current use, gentamicin was the most active, one-half of the strains being susceptible to 12.5 Ag/ml and 75% being inhibited by 50,ug/ml.
Lincomycin analogues. As shown in Fig. 4 , lincomycin, clindaimycin, and demethyl-clindamycin were, for the most part, inactive; only occasional strains were inhibited by 100 Mg/ml, and one-half to three-fourths of the strains were resistant to 200 Mg/ml. Depropyl-clindamycin and U39,745E were somewhat more active, 44% Tetracyclines. The most impressive finding was the nearly uniform susceptibility of all strains of N. asteroides to each of the seven tetracycline analogues that were tested and the marked differences in the relative activity of the individual analogues (Fig. 5) . Only methacycline showed a bimodal distribution of the MIC values, 55% of the strains being inhibited by 12.5 gg/ml, and the MIC for most of the others was 100 ug/ml. By far the most active, and quite uniformly so, was minocycline; the MIC for 90% of the strains was 1.6 or 3.1 Ag/ml, and all were susceptible to 6.3 ,ug/ml. Doxycycline ranked next in activity, but against all of the strains the MIC was four to eight times that of minocycline. Demeclocycline was the least active; the MIC for 50%7o of strains was 25 to 100 ,ug/ml, and almost all of the rest were inhibited by 200 ,g/ml. Chlortetracycline was nearly as active as doxycycline, whereas the activity of oxytetracycline and tetracycline approached that of demeclocycline. Increasing the size of the inoculum had very little effect on the MIC of minocycline.
Other antimicrobial agents. Erythromycin 12%, the MIC was 3.1 to 12.5 ,g/ml, and the remaining 46% were resistant to 100 ,g/ml. Rifampin (Fig. 3 ) was quite active against about one-fifth of the strains (MIC, 6.3 gg or less/ ml), but the MIC for the others was 100 to 400 ug/ml. Spectinomycin (Fig. 3) showed a trimodal distribution: the MIC was 6.3 to 25
,ug/ml for one-fourth of the strains and 100 to 200 ug/ml for one-half of the strains; the other one-fourth of the strains were resistant to 800
,ug/ml. Chloramphenicol (Fig. 2 ) varied widely in its activity: the MIC for three-fourths of the strains ranged from 12.5 to 100 ,ug/ml, and the other strains were resistant to the latter concentration. Vancomycin (Fig. 4) inhibited 15% of the strains at 0.8 ,ug/ml, but the MIC of the rest ranged from 12.5 to 100 jg/ml.
With the inoculum and medium used in our tests, we could not confirm the in vitro susceptibility of the strains of N. asteroides to sulfonamides (4). Sulfadiazine and sulfamethoxazole failed to inhibit all but a few of the strains in concentrations up to 2,000 ug/ml (200 mg/ 100 ml). However, when the inoculum was decreased to 10 to 100 CFU, many strains were susceptible to 6.3 to 50 ug/ml. (4) . The differences in the numbers of strains tested with the individual antibiotics were largely a matter of convenience, but were also related to the amount of growth attained at the time of the tests. Nevertheless, it is clear from the results presented that there were wide variations among strains in their susceptibility to nearly all of the antibiotics, and that the different antibiotics, including those that are closely related in chemical structure, also varied markedly in their activity against the individual strains, despite their being tested at the same time and under the same controlled conditions. It is obvious, therefore, that if the in vitro activity of antimicrobial agents is a major criterion for the choice of therapy, it is essential to test the infected patient's organism for susceptibility, particularly when the patient is not showing a favorable bacteriological and clinical response to the original agent selected, usually a sulfonamide, or when that agent cannot be used because it produces drug reactions. Table 1 lists the range and median of the MIC of each antibiotic and the individual MIC for three strains from our patients.
The ultimate criterion for the proper choice of therapy is the effect it produces in the infected patient. We are presenting elsewhere observations made on two patients with pulmonary nocardiosis in whom sulfonamides could not be used effectively-in one because they failed to produce any favorable bacteriological or clinical effect and in the other because they produced severe drug reactions. In each of these patients, elimination of the Nocardia strain from the sputum and lungs, as well as marked regression in the pulmonary lesions, followed therapy selected on the basis of susceptibility tests. This was accomplished with the combination of erythromycin and ampicillin in the first patient, and with minocycline in the other. We were unable to explain the basis for the "continuous variations" in MIC of the strains tested with some antibiotics, for example, ampicillin, amoxicillin, and epicillin (Fig. 1, lower panel) , in contrast to the biomodal distribution of the MIC of others, such as spectinomycin, rifampin, and neomycin ( Fig. 3) , erythromycin (Fig. 4) , or methacycline (Fig. 5) , as compared with the more uniform susceptibility of all strains to minocycline and most of the other tetracyclines (Fig. 5) .
Tests for susceptibility of Nocardia were also carried out with standard medicated discs by the Bauer-Kirby method (2) modified by the use of cultures standardized by actual counts of the number of CFU. These disc tests were applied to minocycline, tetracycline, ampicillin, and erythromycin, and in each instance they showed a good correlation with the results of the agar dilution method, indicating the feasibility of using the disc susceptibility tests for the choice of antibiotics against nocardial infections. However, as previously reported from this laboratory for strains of Staphylococcus aureus (1), it was shown that the tetracycline disc could not be used to identify strains susceptible to minocycline. Likewise, the minocycline disc did not distinguish tetracyclineresistant from tetracycline-susceptible strains. Also, as in the agar dilution method in which the replica inoculator was used, 23.75-,gg discs of sulfamethoxazole showed no clear zones, confirming the resistance of the strains demonstra- reported synergistic action of ampicillin and trisulfapyrimidines for two of four isolates of N. asteroides and clinical improvement with this combination in four immunologically suppressed patients who had pulmonary infections, It was not our intention to be complete and include all available antibiotics. We limited this study primarily to the common classes of antibiotics other than the polypeptides and to the antimycobacterial agents. In particular, we did not test fusidic acid (3, 4) and capreomycin (11) , which have been found active in vitro against some strains of Nocardia.
